Welcome to our dedicated page for 3D Systems news (Ticker: DDD), a resource for investors and traders seeking the latest updates and insights on 3D Systems stock.
3D Systems Corp (symbol: DDD) is a pioneer in the 3D printing industry, offering a broad array of 3D printing and digital manufacturing solutions. The company's product portfolio includes 3D printers for plastics and metals, materials, software, on-demand manufacturing services, and digital design tools. With over 35 years of experience, 3D Systems is at the forefront of innovation in additive manufacturing, impacting a wide range of industries from healthcare and dental to aerospace, automotive, and durable goods.
3D Systems' operations are segmented into Healthcare Solutions and Industrial Solutions, with a significant portion of its revenue generated from the Industrial segment. The company has a strong global presence with offices and facilities across the Americas, EMEA, and APAC regions, although the majority of its revenue comes from the Americas.
The company's recent projects have showcased its advanced capabilities in both industrial and healthcare applications. For instance, 3D Systems has pioneered a first-to-market solution for jetted, monolithic dentures, combining bespoke materials to deliver high-performance dental prosthetics. This innovation has gained interest from leading dental labs and is expected to receive FDA clearance in the second half of 2024.
On the industrial front, 3D Systems continues to expand its portfolio. Recently, the company has seen growth in its metal 3D printing division with Wilting, an industrial machining and metal 3D printing service provider, adding multiple DMP Flex 350 metal 3D printers to its production line. This expansion will enable Wilting to meet increasing customer demand more efficiently.
Financially, 3D Systems has been proactive in managing its liabilities and maintaining a strong balance sheet. The company recently entered into repurchase agreements to buy back $110 million of its 0% Convertible Senior Notes due 2026, thereby reducing its outstanding debt significantly.
3D Systems' commitment to innovation is further exemplified by its developments in patient-specific medical devices. The FDA recently cleared its VSP® PEEK Cranial Implant solution, designed for use in cranioplasty procedures, which utilizes additive manufacturing to produce highly customized, cost-effective cranial implants.
Looking ahead, 3D Systems aims to harness its leadership in digital dentistry, with plans to expand its product offerings to include night guards and direct-printed clear aligners. The company has also secured a multi-year purchase agreement, valued at nearly a quarter-billion dollars, to support the indirect manufacturing process for clear aligners, a testament to its robust 3D printing technology and market leadership.
3D Systems' unique combination of hardware, software, materials, and services, powered by expert application engineers, ensures they continue to transform industries and empower their customers to innovate. More information on 3D Systems is available at www.3dsystems.com.
3D Systems (NYSE: DDD) has launched VisiJet Wax Jewel Red, a new material designed for jewelry casting that enhances design capabilities and production efficiency. This innovative material allows for more intricate designs, improved durability, and flexibility, addressing the needs of casting houses. It enables same-day pattern printing and casting while reducing waste and operational costs. Planned availability is on September 20, 2021, marking a significant advancement in the 3D printing landscape for jewelry manufacturing.
3D Systems (NYSE: DDD) announces its acquisition of Oqton, a leader in cloud-based Manufacturing Operating Systems (MOS). The $180 million deal aims to enhance digital manufacturing through AI and automation, addressing the growing demand for advanced manufacturing technologies. Operating independently, Oqton will ensure data security for customers. The acquisition is expected to accelerate software revenue, projecting over $100 million by 2025. The deal is anticipated to close in Q4 2021, pending regulatory approvals.
3D Systems has announced Dr. Brent Stucker as the new Chief Scientist to enhance its leadership in additive manufacturing. Previously, he was the Director of Additive Manufacturing at Ansys and co-founded 3DSIM, a pioneer in AM simulation. Dr. Stucker, known for his extensive publications and contributions to industry standards, is set to drive innovation at 3D Systems. CEO Dr. Jeffrey Graves emphasized Stucker's unique qualifications to help meet customer needs and advance the entire additive industry.
3D Systems (NYSE: DDD) has expanded its materials portfolio by introducing Certified Scalmalloy and Certified M789, enhancing its Direct Metal Printing (DMP) capabilities. Scalmalloy features a tensile strength of 520MPa, ideal for aerospace and automotive applications, while M789 offers high-strength molds free of cobalt, certified for DMP. These innovations support faster time to market and improved manufacturing efficiency across various industries including aerospace, motorsports, and energy. Customers can leverage the Application Innovation Group's expertise to certify these materials effectively.
3D Systems Corporation (NYSE:DDD) reported strong Q2 2021 results, with revenue of $162.6 million, marking a 44.1% increase year-over-year. Adjusted EBITDA margin improved to 12.4%, and the company achieved a positive operating cash flow of $13.5 million. The growth was driven by a 68.6% rise in Healthcare revenue and 25.3% in Industrial sales. After divestitures, the balance sheet is set to improve, with cash projected to exceed $500 million. Despite a GAAP loss of $0.08 per share, the company remains optimistic about its growth trajectory and strategic focus on additive manufacturing.
3D Systems has announced the sale of its medical simulation business, Simbionix, to Surgical Science Sweden AB for $305 million. This divestiture is part of 3D Systems' strategy to focus exclusively on additive manufacturing. Following the transaction, 3D Systems will hold approximately $500 million in cash and have no debt. The company aims for growth and margin expansion in the additive manufacturing sector, emphasizing its industry-leading technology and operational efficiency. The completion of the transaction is expected in August 2021, with Simbionix reported sales of $40.8 million in 2020.
3D Systems has introduced the Accura AMX Rigid Black, a groundbreaking production-grade resin designed for large-scale 3D printing. This material, tested for up to eight years of indoor durability and one and a half years outdoors, enables the creation of highly complex, load-bearing parts. Customers across various sectors, including automotive and motorsports, can expect significant performance and cost improvements. The product will be available from July 20, 2021, with early adopters like TOYOTA Gazoo Racing already benefiting from its innovative capabilities.
3D Systems (DDD) announced its second-quarter financial results will be released after market close on August 9, 2021. Following this, a conference call is scheduled for August 10, 2021, at 8:30 a.m. Eastern Time to discuss the results. The company advises investors to consider forward-looking statements that involve risks and uncertainties affecting anticipated outcomes. These statements are based on current expectations and beliefs but may not guarantee future performance. Further details about 3D Systems' offerings in additive manufacturing are available on their website.
3D Systems (NYSE: DDD) announced a partnership with Rodin Cars to produce parts for their upcoming hypercar, the Rodin FZero, using advanced metal additive manufacturing solutions. The collaboration focuses on a first-of-its-kind 8-speed sequential gearbox, custom-designed to enhance performance and reduce weight through 3D printing in Titanium. This gearbox, along with hundreds of bespoke components, will be produced at Rodin's facility using 3D Systems' DMP Factory 500 technology, marking a significant advancement in additive manufacturing's application in high-performance automotive design.
3D Systems (NYSE: DDD) announces the appointment of Dr. David Leigh as Chief Technology Officer for Additive Manufacturing, enhancing innovation in production-scale solutions. Chuck Hull, co-founder, will shift focus to biotechnology, advancing regenerative medicine technologies. This leadership expansion aims to accelerate the company's innovation pace in response to the growing demand for additive manufacturing across healthcare and industrial sectors. Dr. Leigh brings over 30 years of experience, previously serving at EOS and Stratasys, and is expected to strengthen 3D Systems’ technological capabilities.